医学
内科学
脂肪因子
脂肪变性
心脏病学
减肥
2型糖尿病
脂肪肝
舒张期
肥胖
糖尿病
代谢综合征
射血分数
内分泌学
随机对照试验
预加载
心力衰竭
血流动力学
慢性肝病
心输出量
冲程容积
肝病
血压
心肌梗塞
胰岛素
临床试验
胰岛素抵抗
非诺贝特
非酒精性脂肪肝
临床终点
作者
Pranav Ramesh,Loai Althagafi,Kelly S. Parke,Melanie Jane Davies,Gaurav Singh Gulsin,Gerry Patrick McCann,Emer M. Brady
出处
期刊:Diabetology
[Multidisciplinary Digital Publishing Institute]
日期:2026-02-03
卷期号:7 (2): 32-32
标识
DOI:10.3390/diabetology7020032
摘要
Background: Type 2 diabetes (T2D) increases cardiovascular disease (CVD) risk and predisposes individuals to heart failure with preserved ejection fraction. Metabolic dysfunction-associated steatotic liver disease (MASLD), prevalent in T2D, may worsen cardiac remodelling and haemodynamics. This secondary analysis of the DIASTOLIC trial examined the relationship of liver fat to cardiac remodelling in T2D at baseline and after a 12-week intervention or standard care. Methods: Adults with obesity and T2D and matched controls underwent hepatic MRI, cardiac MRI, echocardiography, and adipokine profiling as part of the DIASTOLIC study (NCT02590822). Participants with T2D were randomised to supervised exercise, a low-calorie meal-replacement plan (MRP), or routine care for 12 weeks. A baseline case–control and then pre- and post-analyses in those with T2D were performed. Associations between changes in liver fat and cardiovascular measures were assessed using correlation and adjusted generalised linear models. Results: At baseline, 81 T2D and 35 healthy controls were compared, and 76 subjects with T2D completed the trial. Participants with T2D had ~4× higher hepatic fat and adverse haemodynamics. The MRP arm achieved the greatest reductions in BMI, blood pressure, dysglycaemia, insulin resistance, and hepatic fat (−8.9%), with favourable adipokine changes. Overall, hepatic fat loss was associated with reductions in cardiac index and stroke volume and with additional reductions in end-diastolic volume in the MRP arm, independent of BMI. Conclusions: In T2D, hepatic fat is strongly linked to pathological haemodynamic profiles. Intensive caloric restriction achieves substantial hepatic fat loss and normalisation of hyperdynamic cardiovascular physiology independent of weight loss, identifying hepatic steatosis as a potential therapeutic target for early cardiovascular risk reduction.
科研通智能强力驱动
Strongly Powered by AbleSci AI